3D- QSAR. QSAR A QSAR is a mathematical relationship between a biological activity of a molecular system and its physicochemical parameters. QSAR attempts.

Slides:



Advertisements
Similar presentations
Analysis of High-Throughput Screening Data C371 Fall 2004.
Advertisements

Case Study: Dopamine D 3 Receptor Anthagonists Chapter 3 – Molecular Modeling 1.
Everardo Macias, Patrick Tomboc Eamonn F. Healy, Chemistry Department,
Chiral HPLC.
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Computational Chemistry
6th lecture Modern Methods in Drug Discovery WS07/08 1 More QSAR Problems: Which descriptors to use How to test/validate QSAR equations (continued from.
Cheminformatics II Apr 2010 Postgrad course on Comp Chem Noel M. O’Boyle.
Basic Steps of QSAR/QSPR Investigations
Summary Molecular surfaces QM properties presented on surface Compound screening Pattern matching on surfaces Martin Swain Critical features Dave Whitley.
Quantative Structure- Activity Relationships. Why QSAR? The number of compounds required for synthesis in order to place 10 different groups in 4 positions.
Quantitative Structure-Activity Relationships (QSAR) Comparative Molecular Field Analysis (CoMFA) Gijs Schaftenaar.
Bioinformatics IV Quantitative Structure-Activity Relationships (QSAR) and Comparative Molecular Field Analysis (CoMFA) Martin Ott.
Structural biology and drug design: An overview Olivier Taboureau Assitant professor Chemoinformatics group-CBS-DTU
RAPID: Randomized Pharmacophore Identification for Drug Design PW Finn, LE Kavraki, JC Latombe, R Motwani, C Shelton, S Venkatasubramanian, A Yao Presented.
Molecular Modeling: Statistical Analysis of Complex Data C372 Dr. Kelsey Forsythe.
Quantitative Structure- Activity Relationships (QSAR)
Quantitative Structure-Activity Relationships (QSAR)  Attempts to identify and quantitate physicochemical properties of a drug in relation to its biological.
Lecture 7: Computer aided drug design: Statistical approach. Lecture 7: Computer aided drug design: Statistical approach. Chen Yu Zong Department of Computational.
QSAR Qualitative Structure-Activity Relationships Can one predict activity (or properties in QSPR) simply on the basis of knowledge of the structure of.
Pharmacophore and FTrees
Quantitative Structure Activity Relationships QSAR and 3D-QSAR
Drug Design Process Discovery Phase. Tripos Software n SYBYL & its modules SYBYL, Concord, MOLCAD, SiteId, Advanced Computation, GASP, DISCOtech, HQSAR,
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Molecular Descriptors
Rational Drug Discovery PC session Protein sequence analysis Biocomputing Primary etc structure X-ray crystallography Structural genomics Homology modelling.
- 2013/ D Structures of Biological Macromolecules Part 5: Drug Research and Design Jürgen Sühnel Supplementary Material:
2D-classification and 3D-QSAR research of benzimidazole-based respiratory syncytial virus fusion inhibitors Dingjue Ji, Yaojin Sun Department of Bioinformatics.
Modern Methods in Drug Discovery WS08/09
Similarity Methods C371 Fall 2004.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 13 QUANTITATIVE STRUCTURE- ACTIVITY RELATIONSHIPS (QSAR)
PHYSICOCHEMICAL PRINCIPLES OF DRUG ACTION
1 1 Slide © 2008 Thomson South-Western. All Rights Reserved Chapter 15 Multiple Regression n Multiple Regression Model n Least Squares Method n Multiple.
Molecular Modeling: Conformational Molecular Field Analysis (CoMFA)
Designing a Tri-Peptide based HIV-1 protease inhibitor Presented by, Sushil Kumar Singh IBAB,Bangalore Submitted to Dr. Indira Ghosh AstraZeneca India.
Use of Machine Learning in Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
Quantitative Structure Activity Relationship (QSAR)
20/03/2008 Dept. of Pharmaceutics 1. Use of BIOINFORMATICS in Pharmaciutics 2  Presented By  Shafnan Nazar  Hamid Nasir 
Ligand-based drug discovery No a priori knowledge of the receptor What information can we get from a few active compounds.
3. Statistics Test results on a drug such as (1) with17 variants (No. of compounds, n, = 17 ) differing only in X are tabulated with the values of physical.
Paola Gramatica, Elena Bonfanti, Manuela Pavan and Federica Consolaro QSAR Research Unit, Department of Structural and Functional Biology, University of.
QSAR Study of HIV Protease Inhibitors Using Neural Network and Genetic Algorithm Akmal Aulia, 1 Sunil Kumar, 2 Rajni Garg, * 3 A. Srinivas Reddy, 4 1 Computational.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
Selecting Diverse Sets of Compounds C371 Fall 2004.
Computer-aided drug discovery (CADD)/design methods have played a major role in the development of therapeutically important small molecules for several.
F.Consolaro 1, P.Gramatica 1, H.Walter 2 and R.Altenburger 2 1 QSAR Research Unit - DBSF - University of Insubria - VARESE - ITALY 2 UFZ Centre for Environmental.
Catalyst TM What is Catalyst TM ? Structural databases Designing structural databases Generating conformational models Building multi-conformer databases.
CHE2201, Chapter 2 Learn, 1 Polar Covalent Bonds: Acids and Bases Chapter 2 Suggested Problems ,25-6,31,34,36,39- 40,51-2.
P. Gramatica 1, H. Walter 2 and R. Altenburger 2 1 QSAR Research Unit - DBSF - University of Insubria - VARESE - ITALY 2 UFZ Centre for Environmental Research.
Bonds. Covalent Bonds Atoms share a pair of electrons. Occur between atoms whose outer shells are not full. Covalent bonds are strong chemical bonds,
Use of Machine Learning in Chemoinformatics
2. Hydrophobicity of the Molecule
CoMFA Study of Piperidine Analogues of Cocaine at the Dopamine Transporter: Exploring the Binding Mode of the 3  -Substituent of the Piperidine Ring Using.
Computational Approach for Combinatorial Library Design Journal club-1 Sushil Kumar Singh IBAB, Bangalore.
Molecular mechanics Classical physics, treats atoms as spheres Calculations are rapid, even for large molecules Useful for studying conformations Cannot.
SMA5422: Special Topics in Biotechnology Lecture 11: Computer aided drug design: QSAR approach. SMA5422: Special Topics in Biotechnology Lecture 11: Computer.
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Toxicity vs CHEMICAL space
Chapter 10 Chemical Bonding II
Chapter 10 Chemical Bonding II
Virtual Screening.
Current Status at BioChemtek
Part 1: Molecular Orbitals
What makes a molecule an anaesthetic
Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse intravenous general anaesthetics†   J.C. Sewell, J.W. Sear  British.
New compounds with improved biological activity
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Presentation transcript:

3D- QSAR

QSAR A QSAR is a mathematical relationship between a biological activity of a molecular system and its physicochemical parameters. QSAR attempts to find consistent relationship between biological activity and physicochemical properties, so that these “rules” can be used to evaluate the activity of new compounds.

QSAR and Drug Design QSAR New compounds with improved biological activity Compounds + biological activity

Pysicochemical properties  Hydrophobicity of the molecule (p)  Hydrophobicity of substituents ( π )  Electronic properties of substituents (   Steric properties of substituents (E s )

Hansch Equation Hansch Equation A QSAR equation relating various physicochemical properties to the biological activity of a series of compounds.A QSAR equation relating various physicochemical properties to the biological activity of a series of compounds. Usually includes log P, electronic and steric factorsUsually includes log P, electronic and steric factors Log 1 C      - k (logP) 2 + k 2 logP logP+ k 3  + k 4 E s + k 5 1

Hansch Equation Hansch Equation Log1C        Conclusions: Activity increases if p is +ve (i.e. hydrophobic substituents)Activity increases if p is +ve (i.e. hydrophobic substituents) Activity increases if s is negative (i.e. e-donating substituents)Activity increases if s is negative (i.e. e-donating substituents) Example : Adrenergic blocking activity of  -halo-  -arylamines

Free-Wilson Approach Free-Wilson Approach The biological activity of the parent structure is measured and compared with the activity of analogues bearing different substituentsThe biological activity of the parent structure is measured and compared with the activity of analogues bearing different substituents An equation is derived relating biological activity to the presence or absence of particular substituentsAn equation is derived relating biological activity to the presence or absence of particular substituents Activity = k 1 X 1 + k 2 X 2 +.…k n X n + Z X n is an indicator variable which is given the value 0 or 1 depending on whether the substituent (n) is present or notX n is an indicator variable which is given the value 0 or 1 depending on whether the substituent (n) is present or not The contribution of each substituent (n) to activity is determined by the value of k nThe contribution of each substituent (n) to activity is determined by the value of k n Z is a constant representing the overall activity of the structures studiedZ is a constant representing the overall activity of the structures studied

3D-QSAR 3D-QSAR Physical properties are measured for the molecule as a wholePhysical properties are measured for the molecule as a whole Properties are calculated using computer softwareProperties are calculated using computer software No experimental constants or measurements are involvedNo experimental constants or measurements are involved Properties are known as ‘Fields’Properties are known as ‘Fields’ Steric field - defines the size and shape of the moleculeSteric field - defines the size and shape of the molecule Electrostatic field - defines electron rich/poor regions of moleculeElectrostatic field - defines electron rich/poor regions of molecule Hydrophobic properties are relatively unimportantHydrophobic properties are relatively unimportant Advantages over QSAR No reliance on experimental valuesNo reliance on experimental values Can be applied to molecules with unusual substituentsCan be applied to molecules with unusual substituents Not restricted to molecules of the same structural classNot restricted to molecules of the same structural class Predictive capabilityPredictive capability

QSAR and 3D-QSAR Software Tripos – CoMFA VolSurf MSI – Catalyst Serius

Comparative molecular field analysis (CoMFA) is one of the well known 3D-QSAR descriptors which has been used regularly to produce the three dimensional models to indicate the regions that affect biological activity with a change in the chemical substitution. The advantages of CoMFA are the ability to predict the biological activities of the molecules and to represent the relationships between steric/electrostatic property and biological activity in the form of contour maps gives key features on not only the ligand-receptor interaction but also the topology of the receptor

Active conformation Build 3D model Define pharmacophore

Active conformation Build 3D model Define pharmacophore

3D-QSAR 3D-QSAR Place the pharmacophore into a lattice of grid pointsPlace the pharmacophore into a lattice of grid points Each grid point defines a point in spaceEach grid point defines a point in space Grid points

3D-QSAR 3D-QSAR Each grid point defines a point in spaceEach grid point defines a point in space Grid points..... Position molecule to match the pharmacophorePosition molecule to match the pharmacophore

3D-QSAR 3D-QSAR A probe atom is placed at each grid point in turnA probe atom is placed at each grid point in turn Measure the steric or electrostatic interaction of the probe atomMeasure the steric or electrostatic interaction of the probe atom with the molecule at each grid point..... Probe atom

3D-QSAR 3D-QSAR Method CompoundBiologica l Steric fields (S ) Electrostatic fields (E) activity at grid points ( ) at grid points ( ) S001S002S003S004S005 etcE001E002E003E004E005 etc Tabulate fields for each compound at each grid point Partial least squares analysis (PLS) QSAR equation Activity = aS001 + bS002 +……..mS998 + nE001 +…….+yE998 + z.....

3D-QSAR CASE STUDY 3D-QSAR CASE STUDY Anticholinesterase used in the treatment of Alzheimer’s disease

3D-QSAR CASE STUDY 3D-QSAR CASE STUDY Conclusions Large groups at position 7 are detrimental Groups at positions 6 & 7 should be electron-withdrawing No hydrophobic effect Conventional QSAR Study 12 analogues were synthesised to relate their activity with the hydrophobic, steric and electronic properties of substituents at positions 6 and 7 C  Log1   pIC pIC 50 = MR(R 1 )+ 1.43F(R 1.43F(R 1,R 2 ) Substituents: CH 3, Cl, NO 2, OCH 3, NH 2, F (Spread of values with no correlation)

3D-QSAR CASE STUDY 3D-QSAR CASE STUDY CoMFA Analysis includes tetracyclic anticholinesterase inhibitors (II) Not possible to include above structures in a conventional QSAR analysis since they are a different structural classNot possible to include above structures in a conventional QSAR analysis since they are a different structural class Molecules belonging to different structural classes must be aligned properly according to a shared pharmacophoreMolecules belonging to different structural classes must be aligned properly according to a shared pharmacophore

3D-QSAR CASE STUDY 3D-QSAR CASE STUDY Possible Alignment Overlay Good overlay but assumes similar binding modes

3D-QSAR CASE STUDY 3D-QSAR CASE STUDY Prediction 6-Bromo analogue of tacrine predicted to be active (pIC 50 = 7.40) Actual pIC 50 = 7.18

REFERENCES  QSAR and 3D QSAR in drug design Part1:methodology Hugo Kubinyi  QSAR and 3D QSAR in drug design.Part1:application Hugo Kubinyi  3D QSAR study of Potent Inhibitor of Phosphodiesterase-4 Using a CoMFA Approach(zhaoqi yang and pinghua sun)

Presents by: Azar Imanpoor Super visor: Dr. Parcheh Baf